Gossamer Bio Sets 1-for-80 Reverse Split to Regain Nasdaq Compliance
GOSS sits 32% above its 52-week low of $0.114 on light trading volume (0.3× avg).
Summary
Gossamer Bio's board selected a 1-for-80 reverse stock split, effective September 10, 2026, to regain Nasdaq's $1 minimum bid requirement. The split reduces authorized shares from 4 billion to 50 million and proportionally adjusts convertible notes, warrants, and equity awards. This follows shareholder approval in July and the company's going concern warning and delisting risk disclosed in its Q2 10-Q. The move is a compliance necessity, not a fundamental change, but it removes a near-term delisting overhang. Trading on a split-adjusted basis begins September 11 under the same ticker.
At the time of this announcement, GOSS was trading at $0.15 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $87.9M. The 52-week trading range was $0.11 to $3.87. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: BusinessWire.